Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial

• Roncalli, J. https://orcid.org/0000-0002-4093-0435
• Roubille, F. https://orcid.org/0000-0002-5288-9687
• Cottin, Y. https://orcid.org/0000-0002-5176-5121
• Leroux, L.
• Mathur, A. https://orcid.org/0000-0001-7941-9653
• Irving, J.
• Khan, S.Q.
• Meneveau, N.
• Bresson, D. https://orcid.org/0000-0001-5891-855X
• Hovasse, T.
• Pompilio, G.
• Matta, A.
• Henon, P.
• Trebuchet, G.
• de Kalbermatten, M.
• Garitaonandia, I.
• Saloux, E. https://orcid.org/0000-0002-3817-9961
• Manrique, A. https://orcid.org/0000-0002-1578-0922
• Meyer, N.
• Marie, P.-Y. https://orcid.org/0000-0001-7319-3737
• Bhatt, D.L. https://orcid.org/0000-0002-1278-6245
• Solomon, S.D.
• Montalescot, G.
• Newby, D.E.
• Zannad, F. https://orcid.org/0000-0001-7456-1570
• Baumbach, A.
• Chopard, R.
• Townend, J.
• George, S.
• Seguy, B.
• Gerbaud, E.
• Cruden, N.
• Mills, N.
• Rochette, G.B.
• Vanzetto, G.
• Greenwood, J.
• Wheatcroft, S. https://orcid.org/0000-0002-6741-9012
• Lefevre, T.
• Benamer, H.
• Delseny, D.
• Bouisset, F.

© 2025, The Authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY-NC-ND 4.0).

• Accepted: 23 July 2025
• Published (online): 10 September 2025
• Published: 1 November 2025